Current portfolio

Envirotainer

A global provider of mission critical biopharma transport services

Envirotainer is the global market leader in mission critical temperature controlled supply chain solutions for the transportations of biopharmaceuticals

  • Sector
    Healthcare
  • Country
    Sweden
  • Responsible Advisor
    Ali Farahani
  • Entry
    2022
  • Web
Logo

Envirotainer was established in 1985 and is headquartered in Stockholm, Sweden. The company is a global market leader in air transport of temperature sensitive pharmaceuticals. With the world's largest fleet of specialized containers and close collaboration with airlines and freight forwarders, Envirotainer meets the pharmaceutical industry's complex need for fast and safe cold chain shipments where the pharmaceutical maintains exactly the right temperature throughout transport - from factory to end user.

Biological drugs are very temperature sensitive and large values are lost every year due to shortcomings in the logistics chain. Envirotainer's solutions provide the opportunity to meet complex and regulatory requirements when transporting these medicines under controlled temperatures. Thus, the company has a key role to play in ensuring that vital treatments, such as vaccines, insulin and oncological drugs, reach patients safely. Envirotainer delivered two million doses of medication every day in 2021.

Market trends and drivers

Envirotainer is uniquely positioned as the market leader and industry gold standard, in a highly attractive, resilient and strongly growing niche market with exposure to the underlying biopharma market. The market growth is supported by secular trends such as growing and aging global population, stricter pharma regulatory requirements and innovation of pharma products requiring cold chain solutions.

Millions of people across the globe depend on the safe delivery of biopharmaceuticals that require temperature control to maintain their integrity and quality. Today, lack of access to medicines is a cause for distress that disproportionately impacts underserved communities, whose situation is likely to be exacerbated by chronic diseases resulting from changing diets and lifestyles, as well as from air and water pollution. Envirotainer expands access to vital pharmaceuticals and vaccines through its patient-safe, reliable and efficient cold chain solutions, which also offer one of the lowest carbon footprint solutions in the industry.

Investment potential

EQT Private Equity will support Envirotainer in its next phase of growth by accelerating expansion in APAC and further driving growth in its other core markets, while investing behind new technology innovations, digitalization and sustainability in its operations.

Board of directors

  • Chairperson
    Jarl Dahlfors
  • Board member
    Ali Farahani
  • Board member
    Simon Tillmo
  • Board member
    Camilla Macapili Languille
  • Board member
    Pontus Petterson
  • Board member
    Wes Wheeler
  • Board member
    Andreas Jacobsson

Management

  • CEO
    Peter Gisel-Ekdahl
  • CFO
    Jonas Söderkvist

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news
Preferred language
EQT logo
© EQT AB 2022. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180